BG23001A3 - Метод за получаване на производни на допамина - Google Patents

Метод за получаване на производни на допамина

Info

Publication number
BG23001A3
BG23001A3 BG023268A BG2626873A BG23001A3 BG 23001 A3 BG23001 A3 BG 23001A3 BG 023268 A BG023268 A BG 023268A BG 2626873 A BG2626873 A BG 2626873A BG 23001 A3 BG23001 A3 BG 23001A3
Authority
BG
Bulgaria
Prior art keywords
dopamine derivatives
obtaining
obtaining dopamine
derivatives
dopamine
Prior art date
Application number
BG023268A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ronald Juttle
Jack Mills
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG23001(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG23001A3 publication Critical patent/BG23001A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG023268A 1972-04-12 1973-04-11 Метод за получаване на производни на допамина BG23001A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (1)

Publication Number Publication Date
BG23001A3 true BG23001A3 (bg) 1977-05-20

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
BG023268A BG23001A3 (bg) 1972-04-12 1973-04-11 Метод за получаване на производни на допамина

Country Status (31)

Country Link
JP (2) JPS5825656B2 (lv)
KR (1) KR790000113B1 (lv)
AR (1) AR203822A1 (lv)
AT (1) AT323719B (lv)
AU (1) AU472734B2 (lv)
BE (1) BE798051A (lv)
BG (1) BG23001A3 (lv)
CA (1) CA1018188A (lv)
CH (2) CH569691A5 (lv)
CS (2) CS190448B2 (lv)
CY (1) CY963A (lv)
DD (1) DD107670B3 (lv)
DE (1) DE2317710C2 (lv)
DK (1) DK142750C (lv)
ES (1) ES413639A1 (lv)
FR (1) FR2182947B1 (lv)
GB (1) GB1392674A (lv)
HK (1) HK50178A (lv)
HU (2) HU167597B (lv)
IE (1) IE37511B1 (lv)
IL (1) IL42016A (lv)
KE (1) KE2870A (lv)
MY (1) MY7800381A (lv)
NL (1) NL174459C (lv)
PH (1) PH11041A (lv)
PL (2) PL90695B1 (lv)
RO (2) RO65105A (lv)
SE (1) SE399064B (lv)
SU (1) SU496719A3 (lv)
YU (2) YU36483B (lv)
ZA (1) ZA732136B (lv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (lv) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (lv) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (de) * 1993-04-13 1998-01-22 Duphar Int Res Herstellung von Dobutamin Verbindungen
PT1546088E (pt) 2002-10-03 2015-03-16 Novaremed Ltd Compostos para utilização no tratamento de doenças auto-imunes, de doenças imuno-alérgicas e de rejeição de órgãos ou tecidos transplantados
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
JP2013501006A (ja) 2009-07-31 2013-01-10 コグニション セラピューティクス インク． 認知機能低下の阻害剤
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
BR112014004414A2 (pt) * 2011-08-25 2017-03-28 Cognition Therapeutics Inc composições e métodos para tratar doença neurodegenerativa
BR112016017808B1 (pt) 2014-01-31 2022-07-12 Cognition Therapeutics, Inc Composto ou sal farmaceuticamente aceitável, uso de um composto e composição para a inibição de um efeito betaamilóide numa célula neuronal
KR102614814B1 (ko) 2017-05-15 2023-12-20 카그니션 테라퓨틱스, 인코퍼레이티드 신경변성 질환 치료용 조성물
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
YU36483B (en) 1984-02-29
AR203822A1 (es) 1975-10-31
CA1018188A (en) 1977-09-27
IL42016A (en) 1976-05-31
YU97673A (en) 1982-02-25
IE37511B1 (en) 1977-08-03
DE2317710C2 (de) 1983-08-04
PL94207B1 (lv) 1977-07-30
ZA732136B (en) 1974-03-27
CH580563A5 (lv) 1976-10-15
HU166213B (lv) 1975-02-28
AU5438573A (en) 1974-10-17
DK142750C (da) 1981-08-17
DD107670B3 (de) 1988-04-06
YU37113B (en) 1984-08-31
NL7305097A (lv) 1973-10-16
DD107670A5 (de) 1974-08-12
JPS5825656B2 (ja) 1983-05-28
FR2182947A1 (lv) 1973-12-14
RO65105A (ro) 1980-01-15
CH569691A5 (lv) 1975-11-28
KR790000113B1 (en) 1979-03-20
JPS58131945A (ja) 1983-08-06
CY963A (en) 1978-12-22
SU496719A3 (ru) 1975-12-25
BE798051A (fr) 1973-10-11
AU472734B2 (en) 1976-06-03
SE399064B (sv) 1978-01-30
PH11041A (en) 1977-10-25
DE2317710A1 (de) 1973-10-18
HU167597B (lv) 1975-11-28
GB1392674A (en) 1975-04-30
HK50178A (en) 1978-09-15
DK142750B (da) 1981-01-12
IL42016A0 (en) 1973-06-29
JPS497237A (lv) 1974-01-22
NL174459C (nl) 1984-06-18
CS190406B2 (en) 1979-05-31
KE2870A (en) 1978-09-01
YU321279A (en) 1983-04-27
FR2182947B1 (lv) 1976-07-02
AT323719B (de) 1975-07-25
NL174459B (nl) 1984-01-16
PL90695B1 (lv) 1977-01-31
JPS6221343B2 (lv) 1987-05-12
RO70892A (ro) 1982-02-26
CS190448B2 (en) 1979-05-31
MY7800381A (en) 1978-12-31
ES413639A1 (es) 1976-01-16

Similar Documents

Publication Publication Date Title
BG21408A3 (bg) Метод за получаване на бензоксазолови производни
BG20352A3 (bg) Метод за получаване на пиридил-фенил оксиалкани
BG23001A3 (bg) Метод за получаване на производни на допамина
BG17785A3 (bg) Метод за получаване на нови азетинови производни
BG21861A3 (bg) Метод за получаване на 3-хидрокси-цефалоспорини
BG22817A3 (bg) Метод за получаване на 1-хидрокси-2-пиридони
BG21851A3 (bg) Метод за получаване на производни на 1-фенокси -3- амино-пропан-2-ол
BG21234A3 (bg) Метод за получаване на цефалоспоринови производни
BG22832A3 (bg) Метод за получаване на лизергични амиди
BG21010A3 (bg) Метод за получаване на бифенилови производни
BG21221A3 (bg) Метод за получаване на пиперазинови производни
BG22826A3 (bg) Метод за получаване на оксазоли
BG22825A3 (bg) Метод за получаване на нови оксазолидини
BG17312A3 (bg) Метод за получаване на нови производни на тропан-3-ола
BG21197A3 (bg) Метод за получаване на нови биденилови деривати
BG18856A3 (bg) Метод за получаване на аминоетанолови производни
BG23007A3 (bg) Метод за получаване на циклобутанови производни
BG26205A4 (bg) Метод за получаване на м-диоксан-5-метиламини
BG23542A3 (bg) Метод за получаване на еверниномицинови производни
BG21231A3 (bg) Метод за получаване на сулфоокис на феноокисиметил пенецелина
BG19122A3 (bg) Метод за получаване на борнаминови производни
BG20558A3 (bg) Метод за получаване на сирил-пиридини
BG21607A3 (bg) Метод за получаване на псевдотризахариди
BG22382A3 (bg) Метод за получаване на 2-амино-бензиламини
SU506295A3 (ru) Способ получени производных аминопиразолпиримидина